We are live on ! Find out more
CCIA

Campbell & Co Investment Adviser Portfolio holdings

AUM $1.91B
1-Year Est. Return 17.57%
This Fund
S&P 500
This Quarter Est. Return
-4.35%
1 Year Est. Return
+17.57%
3 Year Est. Return
+30.96%
5 Year Est. Return
+33.24%
10 Year Est. Return
+189.91%
AUM
$1.3B
AUM Growth
+$7.71M
Cap. Flow
+$92.4M
Cap. Flow %
7.09%
Top 10 Hldgs %
6.04%
Holding
1,409
New
392
Increased
321
Reduced
279
Closed
417

Top Buys

Rank Stock Value
1
SYF icon
Synchrony
SYF
+$9.84M
2
LH icon
Labcorp
LH
+$8.89M
3
HUBB icon
Hubbell
HUBB
+$7.76M
4
SNY icon
Sanofi
SNY
+$7.7M
5
JHG
Janus Henderson
JHG
+$7.68M

Top Sells

Rank Stock Value
1
ICE icon
Intercontinental Exchange
ICE
+$10.4M
2
FAST icon
Fastenal
FAST
+$10.2M
3
HCA icon
HCA Healthcare
HCA
+$9.44M
4
SCHW
Charles Schwab
SCHW
+$9.09M
5
NVS icon
Novartis
NVS
+$9.01M

Sector Composition

Rank Sector Weight
1 Financials 17%
2 Healthcare 16.16%
3 Consumer Discretionary 11.61%
4 Industrials 11.13%
5 Technology 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UMBF icon
451
UMB Financial
UMBF
$11.4B
$942K 0.07%
9,319
+6,271
+206% +$691K
STGW icon
452
Stagwell
STGW
$2.29B
$941K 0.07%
155,512
+95,364
+159% +$600K
MGPI icon
453
MGP Ingredients
MGPI
$381M
$940K 0.07%
32,006
+4,168
+15% +$139K
UBSI icon
454
United Bankshares
UBSI
$6.66B
$937K 0.07%
27,018
-1,821
-6% -$66.7K
FSK icon
455
FS KKR Capital
FSK
$3.36B
$937K 0.07%
44,703
+8,762
+24% +$196K
NHI icon
456
National Health Investors
NHI
$3.47B
$936K 0.07%
12,671
+3,549
+39% +$250K
ORA icon
457
Ormat Technologies
ORA
$6.97B
$935K 0.07%
+13,210
New +$895K
AWI icon
458
Armstrong World Industries
AWI
$7.75B
$933K 0.07%
6,623
-4,826
-42% -$711K
BDC icon
459
Belden
BDC
$5.39B
$932K 0.07%
9,295
+6,011
+183% +$667K
DT icon
460
Dynatrace
DT
$14.3B
$927K 0.07%
19,665
+6,881
+54% +$376K
DNLI icon
461
Denali Therapeutics
DNLI
$4.04B
$927K 0.07%
68,185
+30,500
+81% +$584K
LKFN icon
462
Lakeland Financial Corp
LKFN
$1.55B
$926K 0.07%
+15,578
New +$1.02M
BABA icon
463
Alibaba
BABA
$300B
$924K 0.07%
6,986
+4,034
+137% +$465K
PTGX icon
464
Protagonist Therapeutics
PTGX
$9.84B
$920K 0.07%
+19,015
New +$797K
CSTL icon
465
Castle Biosciences
CSTL
$960M
$918K 0.07%
45,849
-471
-1% -$11.7K
KOP icon
466
Koppers
KOP
$857M
$914K 0.07%
32,627
+17,600
+117% +$530K
APOG icon
467
Apogee Enterprises
APOG
$897M
$911K 0.07%
19,662
+15,521
+375% +$792K
GPC icon
468
Genuine Parts
GPC
$18.5B
$909K 0.07%
+7,631
New +$918K
QNST icon
469
QuinStreet
QNST
$1.19B
$908K 0.07%
50,922
+17,897
+54% +$375K
ADSK icon
470
Autodesk
ADSK
$52.7B
$907K 0.07%
3,466
+1,495
+76% +$425K
PAHC icon
471
Phibro Animal Health
PAHC
$1.37B
$906K 0.07%
42,422
+7,822
+23% +$175K
TMHC
472
DELISTED
Taylor Morrison
TMHC
$906K 0.07%
+15,084
New +$939K
DOX icon
473
Amdocs
DOX
$6.08B
$905K 0.07%
9,890
-7,682
-44% -$671K
PFG icon
474
Principal Financial Group
PFG
$24.4B
$898K 0.07%
+10,642
New +$885K
LQDT icon
475
Liquidity Services
LQDT
$1.35B
$894K 0.07%
28,831
+6,420
+29% +$213K
17 18
19
20 21

Similar funds

BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.28% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.9B AUM 2.22% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return

Campbell & Co Investment Adviser's Q1 2025 Portfolio in Review

As of Q1 2025, Campbell & Co Investment Adviser held 1,409 positions worth $1.3B, up 0.6% from $1.3B the previous quarter. Its ten largest holdings account for 6% of the portfolio.

Campbell & Co Investment Adviser deployed $92.4M of net new capital in Q1 2025, opening 392 new positions and adding to 321 existing holdings. Its largest new stake was Synchrony: 159,080 shares worth $8.42M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Novartis, an estimated $9.01M trimmed.

  • Campbell & Co Investment Adviser's largest Q1 2025 buy was Synchrony: 159,080 shares worth $8.42M.
  • Campbell & Co Investment Adviser added most to Labcorp in Q1 2025, an estimated $8.89M increase.
  • Campbell & Co Investment Adviser's biggest Q1 2025 reduction was Novartis, cutting an estimated $9.01M.
  • Campbell & Co Investment Adviser fully exited Intercontinental Exchange in Q1 2025, selling an estimated $10.4M.
  • Campbell & Co Investment Adviser's ten largest holdings make up 6% of its $1.3B portfolio in Q1 2025.
  • Campbell & Co Investment Adviser opened 392 new positions and closed 417 in Q1 2025.
  • Campbell & Co Investment Adviser's portfolio value rose 0.6% quarter-over-quarter to $1.3B.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2025, filed 14 May 2025.